Skip to main content

Table 4 Haematological and biochemical assessments

From: Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial

 

Quinine plus clindamycin

Artemether-lumefantrine

P-value

 

No. tested

Mean (SD)

No. tested

Mean (SD)

White blood cell count (109/L)

 Day 0

132

9.31 (4.2)

134

10.10 (7.8)

0.311

 Day 28

51

7.92 (3.3)

118

7.71 (3.3)

0.701

 P value

0.035

0.002

 

Lymphocyte count (%)

 Day 0

131

30.06 (12.7)

133

34.5 (42.1)

0.252

 Day 28

50

45.2 (14.7)

118

47.4 (13.5)

0.345

 

 < 0.0001

0.0016

 

Red blood cell count (1012/L)

 Day 0

132

4.38 (4.3)

133

3.93 (1.00)

0.451

 Day 28

51

4.56 (1.05)

118

4.39 (0.90)

0.275

 

0.768

0.0002

 

Haemoglobin concentration (g/dl)

 Day 0

131

9.64 (1.8)

133

9.8 (1.6)

0.425

 Day 28

51

10.9 (1.5)

118

10.6 (1.2)

0.070

 

 < 0.0001

 < 0.0001

 

Alkaline phosphatase concentration (U/L)

Day 0

164

21.1 (14.7)

164

20.5 (18.5)

0.738

Day 28

58

17.7 (8.7)

129

17.7 (7.7)

0.997

 

0.098

0.108

 

Creatinine concentration (µmol/L)

 Day 0

164

44.3 (16.5)

164

46.5 (31.9)

0.432

 Day 28

58

49.2 (16.6)

129

46.1 (15.2)

0.219

 

0.054

0.896

Â